1. Sun, Xin, Ye, Guiqin, Li, Jiuzhou, Bai, Gongxun, Zhang, Jianbin. . Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer. In Clinical and translational medicine, 13, e1457. doi:10.1002/ctm2.1457. https://pubmed.ncbi.nlm.nih.gov/37877353/
2. Han, Chenying, Hu, Chenchen, Liu, Tianyue, Yang, Kun, Yang, Shuya. 2024. IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD. In Cell death & disease, 15, 138. doi:10.1038/s41419-024-06520-0. https://pubmed.ncbi.nlm.nih.gov/38355626/
3. Dai, Weiwei, Tian, Ruotong, Yu, Liubing, Chen, Juxiang, Shu, Minfeng. 2024. Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma. In Nature communications, 15, 131. doi:10.1038/s41467-023-44576-2. https://pubmed.ncbi.nlm.nih.gov/38167409/
4. Pan, Ziwen, Zhao, Rongrong, Li, Boyan, Xue, Hao, Li, Gang. 2022. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. In Molecular cancer, 21, 16. doi:10.1186/s12943-021-01485-6. https://pubmed.ncbi.nlm.nih.gov/35031058/
5. Li, Ke, Guo, Jiawei, Ming, Yue, Liu, Wenrong, Peng, Yong. 2023. A circular RNA activated by TGFβ promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability. In Nature communications, 14, 6876. doi:10.1038/s41467-023-42571-1. https://pubmed.ncbi.nlm.nih.gov/37898647/
6. Liu, Chang, Dou, Xiaoyang, Zhao, Yutao, Xiao, Yu, He, Chuan. 2024. IGF2BP3 promotes mRNA degradation through internal m7G modification. In Nature communications, 15, 7421. doi:10.1038/s41467-024-51634-w. https://pubmed.ncbi.nlm.nih.gov/39198433/
7. Zhou, Tiantian, Xiao, Ziyi, Lu, Jin, Bo, Le, Wang, Jinhua. 2023. IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer. In American journal of cancer research, 13, 5289-5305. doi:. https://pubmed.ncbi.nlm.nih.gov/38058838/
8. Xu, Xin, Cui, Jiangtao, Wang, Hong, Wang, Jiayi, Qiao, Yongxia. 2022. IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells. In Materials today. Bio, 17, 100503. doi:10.1016/j.mtbio.2022.100503. https://pubmed.ncbi.nlm.nih.gov/36457846/
9. Lv, Lei, Wei, Qinqin, Zhang, Jianxiao, Bian, Po, Yi, Qiyi. 2024. IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development. In Cellular & molecular biology letters, 29, 39. doi:10.1186/s11658-024-00545-1. https://pubmed.ncbi.nlm.nih.gov/38504159/
智鼠故事 
